Transient expression of CARs in effector T-cells was recently shown after the injection of mice with poly-beta-amino-esters (PBAE) nano-vehicles containing an anti-CD8 or anti-CD3 antibody and a mRNA encoding a CAR or TCR, leading to tumor regression in several tumor models [77]. This evidence concerns the gene CD8A and neoplasm.